garber a j diabetes obes metab 4 s5-12 2002 - BMJ 200032140512 Google Scholar UK Prospective cara mengatasi diabetes kering secara alami Diabetes Study UKPDS Group Garber AJ Larsen J Schneider SH Piper BA Henry D Simultaneous glyburidemetformin monotherapy is superior to component monotherapy as initial pharmacological treatment for type 2 diabetes Diab Obes Metab 2002420108 Obesity and type 2 diabetes which patients are at risk Garber AJ 1 Author information Diabetes Obesity Metabolism 01 Jan 2002 4 Suppl 1 S512 DOI 101046j14628902200100038x PMID 11843949 Review Share this article Share with email Share with twitter Share with linkedin Share with facebook Diabetes Obes Metab 4 Suppl 1S1925 01 Jan 2002 Cited by 6 articles PMID The prevalence of type 2 diabetes T2D worldwide will reach 380 million by 2025 with comorbid obesity in 6090 of subjects This global epidemic combined with the findings of suboptimal glycaemic control in many subjects and treatmentrelated adverse effects such as hypoglycaemia and weight gain has created a need for ongoing advances in therapies In 2002 12 we reported a systematic review of oral agents for type 2 diabetes in which we assessed the efficacy of these drugs both as monotherapy and in combination and discussed evidencebased treatment strategies Now 3 years later with a 50 increase in the number of published trials in this area we reassess the literature Individuals with diabetes are at high risk of cardiovascular CV disease a risk that is significantly greater in the presence of traditional CV risk factors hyperlipidaemia hypertension prothrombotic state Diabetes Obes Metab 2002 Jan4 Suppl 1S512 doi Author Alan J Garber 1 Affiliation 1 Baylor College of Medicine Houston Oral Agents for Type 2 Diabetes An Update Obesity and type 2 diabetes which patients are at risk Garber Diabetes Obes Metab 2010 Apr 12 432333 PubMed 20380653 merk susu yang bagus untuk diabetes 2 Diabetes Obes Metab 2002 Nov 4 636875 2002 PubMed 12406033 17 Garber A Henry RR Ratner R et al Liraglutide a oncedaily human glucagonlike peptide 1 analogue provides sustained improvements in glycaemic control and weight for 2 years as Diabetes and obesity therapeutic targeting and risk reduction a Attenuating CV risk factors in patients with diabetes clinical References Diabetes Medications for Adults With Type 2 Diabetes An Current challenges in type 2 diabetes Garber 2012 Diabetes Attenuating CV risk factors in patients with diabetes clinical Garber AJ Larsen J Schneider SH et al Simultaneous glyburidemetformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes Diabetes Obes Metab 2002 May 4 32018 2002 Diabetes Obes Metab 2010 Apr 12 432333 PubMed 20380653 References Diabetes Medications for Adults With Type 2 Diabetes An A J Garber Departments of Medicine Biochemistry and Molecular Biology and Molecular and Cellular Biology Baylor College of Medicine Houston TX USA IGT all of which indicate high risk for type 2 diabetes T2DM This paper reviews the progression from obesity to diabetes identifying physiological changes that occur along this Overcoming the barriers to effective glycaemic control for type 2 diabetes Obesity is a major risk factor for the development of diabetes and predisposes individuals to hypertension and dyslipidaemia Together these pathologies increase the risk for cardiovascular disease CVD the major cause of morbidity and mortality in type 2 diabetes mellitus T2DM Diabetes Obes Metab 2010 Apr12426787 doi 101111j Diabetes Obes Metab 2012 May145399408 doi 101111j14631326201101536x Epub 2011 Dec 27 Author A J Garber 1 Affiliation 1 Departments of Medicine Biochemistry and Molecular Biology and Molecular and Cellular Biology Baylor College of gizi ibu hamil diabetes Medicine Houston TX USA
tanda orang terkena diabetes melitus
biodisc diabetes
